Cargando…
Circulating Th17, Th22, and Th1 Cells Are Elevated in the Guillain-Barré Syndrome and Downregulated by IVIg Treatments
The Guillain-Barré syndrome (GBS) is considered a T helper 1 (Th1) cells-mediated acute inflammatory peripheral neuropathy. However, some changes in GBS could not be explained completely by Th1 cells pathogenic role. Recently, Th17 cells have been identified and can mediate tissue inflammation and a...
Autores principales: | Li, Shujuan, Jin, Tao, Zhang, Hong-Liang, Yu, Hong, Meng, Fanhua, Concha Quezada, Hernan, Zhu, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4036596/ https://www.ncbi.nlm.nih.gov/pubmed/24899787 http://dx.doi.org/10.1155/2014/740947 |
Ejemplares similares
-
IL-17 and IL-22 in Cerebrospinal Fluid and Plasma Are Elevated in Guillain-Barré Syndrome
por: Li, Shujuan, et al.
Publicado: (2012) -
Elevated Frequencies of Circulating Th22 Cell in Addition to Th17 Cell and Th17/Th1 Cell in Patients with Acute Coronary Syndrome
por: Zhang, Lei, et al.
Publicado: (2013) -
IVIG Treatment and Prognosis in Guillain–Barré Syndrome
por: van Doorn, Pieter A., et al.
Publicado: (2010) -
Circulating Th22 cells, as well as Th17 cells, are elevated in patients with renal cell carcinoma
por: Peng, Zhiguo, et al.
Publicado: (2021) -
IVIg‐induced plasmablasts in patients with Guillain‐Barré syndrome
por: Brem, Maarten D., et al.
Publicado: (2018)